Mid-trimester triple test levels in early and late onset severe pre-eclampsia

Prenatal Diagnosis

Volumn 22, Issue 7, 2002, Pages 579-582

  Shenhav, Simon ^a   Gemer, Ofer ^a,b   Sassoon, Essie ^a   Volodarsky, Michael ^a   Peled, Ronit ^a   Segal, Shmuel ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BARZILAI MEDICAL CENTER   (Israel)

Author keywords

Early onset pre eclampsia; HCG; Late onset pre eclampsia; Maternal serum alpha fetoprotein; Maternal serum unconjugated oestriol

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL; BIOLOGICAL MARKER;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GESTATIONAL AGE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; PREDICTION; PREECLAMPSIA; PRIORITY JOURNAL; BLOOD; HYPERTENSION; PATHOPHYSIOLOGY; PREGNANCY; PROTEINURIA; RETROSPECTIVE STUDY; SECOND TRIMESTER PREGNANCY;

ADULT; ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN; FEMALE; HUMAN; HYPERTENSION; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PROTEINURIA; RETROSPECTIVE STUDIES; HUMANS;

EID: 0035990124     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.365     Document Type: Article

References (42)

1. Elevated second trimester maternal serum hCG or in combination with elevated alpha-fetoprotein
2. Down syndrome and open neural tube defect screen-positive pregnancies: Premature delivery and premature placental karyotyping
3. Elevated maternal serum alpha-fetoprotein with low unconjugated oestriol and the risk for lethal perinatal outcome
4. The association of antiphospholipid antibodies with severe preeclampsia
5. Outcome of pregnancy in patients with unexplained elevated or low levels of maternal serum alphafetoprotein
6. Family history of pre-eclampsia as a predictor for pre-eclampsia in primigravida
7. Risks associated with an elevated maternal serum alpha fetoprotein level
8. Predicting pregnancy outcome from the degree of maternal serum alpha-fetoprotein elevation
9. Underlying disorders associated with severe early onset pre-eclampsia
10. Effect of hypoxia on throphoblast in organ culture. A morphologic and autoradiographic study
11. Placental vascular lesions and likelihood of diagnosis of pre-eclampsia
12. Steroid sulfatase deficiency diagnosed in utero, following low maternal serum unconjugated oestriel levels
13. The association between unexplained second-trimester maternal serum hCG elevation and pregnancy complications
14. Elevated second trimester maternal serum β-hCG concentrations and subsequent adverse pregnancy outcome
15. Velamentous umbilical cord insertion may be suspected from maternal serum α-fetoprotein and hCG
16. Sonography of placental abnormalites and oligohydramnios in woman with elevated alpha-fetoprotein levels: Comparison with control subjects
17. Association of low unconjugated oestriol in the second trimester and adverse pregnancy outcome
18. Second-trimester maternal serum alpha-fetoprotein and risk of adverse pregnancy outcome
19. Pathologic features of the placenta in women with severe pregnancy complications and thrombophilia
20. Maternal serum triple analyte screening and adverse pregnancy outcome
21. The relation between serum markers in the second trimester and placental pathology: A study on extremely small for gestational age fetuses
22. Placental mosaicism is associated with unexplained second-trimester elevation of MShCG levels, but not with elevation of MSAFP levels
23. Renal disease in women with severe pre-eclampsia or gestational proteinuria
24. Report on high blood pressure in pregnancy
25. Heterogenous causes constituting the single syndrome of preeclampsia: A hypothesis and its implications
26. A prospective controlled multicenter study on the obstetric risk of pregnant women with antiphospholipid antibodies
27. Immunology of pre-eclampsia
28. Pregnancy outcomes after increasing maternal serum alpha-fetoprotein levels
29. Placental pathology at term associated with elevated midtrimester maternal serum alpha-fetoprotein concentration
30. Placental pathologic features of preterm pre-eclampsia
31. Clinical correlations of patterns of placental pathology in preterm pre-eclampsia
32. Pregnancy outcome in women with low mid-trimester maternal serum unconjugated oestriol
33. Pregnancy outcome for women with low levels of maternal serum unconjugated oestriol on second-trimester screening
34. Severe pre-eclampsia in the second trimester: Recurrence risk and long-term prognosis
35. Hypertension during pregnancy in insulin-dependent diabetic women
36. Fetal growth in patients with elevated maternal serum hCG levels
37. Histomorphometry of the human placenta in maternal pre-eclampsia
38. Pre-eclampsia and trisomy 13
39. Second-trimester maternal serum alpha-fetoprotein levels and the risks of subsequent fetal death
40. Elevated second-trimester human chorionic gonadotropin levels in association with poor pregnancy outcome
41. Elevated maternal serum alpha-fetoprotein levels and midtrimester placental abnormalities in relation to subsequent adverse pregnancy outcomes
42. Second-trimester maternal serum marker screening: Maternal serum alphafetoprotein, beta-human chorionic gonadotropin, oestriol, and their various combinations as predictors of pregnancy outcome